Envoy Medical, Inc. Class A Common Stock earnings per share and revenue
On Nov 10, 2025, COCH reported earnings of -0.34 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -7.53% surprise. Revenue reached 42.00 thousand, compared to an expected 71.40 thousand, with a -41.18% difference. The market reacted with a -0.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 56.10 thousand USD, implying an decrease of -5.88% EPS, and increase of 33.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were Envoy Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Envoy Medical, Inc. Class A Common Stock reported EPS of -$0.34, missing estimates by -7.53%, and revenue of $42.00K, -41.18% below expectations.
How did the market react to Envoy Medical, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -0.34%, changed from $0.70 before the earnings release to $0.70 the day after.
When is Envoy Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 31, 2026.
What are the forecasts for Envoy Medical, Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.32 and revenue of $56.10K for Q4 2025.